SCYNEXIS to Participate in the Maxim Group Virtual Healthcare Conference Jun 15, 2023 04:10PM
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants Apr 26, 2022 05:18PM
Scynexis (SCYX) Prices $45M Stock and Warrant Offering at $3/sh Apr 22, 2022 08:17AM
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants Apr 22, 2022 08:15AM
SCYNEXIS to Participate in Upcoming Scientific Conferences and Events Mar 2, 2022 08:30AM


Feb 25, 2021 04:15PM SCYNEXIS to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
Feb 17, 2021 10:46AM SCYNEXIS (SCYX) PT Raised to $22 at Maxim Group
Jan 22, 2021 09:23AM Pre-Open Stock Movers 01/22: (ADMP) (CLII) (SCYX) Higher; (PGEN) (IBM) (GSL) Lower (more...)
Apr 28, 2020 08:00AM SCYNEXIS to Participate in Antifungals Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector
Dec 12, 2019 12:46PM SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
Nov 7, 2019 01:43PM SCYNEXIS (SCYX) Should Be Up, Now Down on Good Phase 3 Readout - Maxim Group
Oct 15, 2018 10:58AM SCYNEXIS (SCYX) PT Lowered to $4 at Maxim Group, Keeps 'Buy'
Jun 27, 2018 07:27AM Maxim Group Starts SCYNEXIS (SCYX) at Buy